Loading...

£210 Million Allocated to Combat Deadly Antimicrobial Resistance

The UK government has announced a monumental commitment of £210 million to address one of the most pressing global health threats: antimicrobial resistance (AMR). 

The Challenge of Antimicrobial Resistance AMR occurs when bacteria, viruses, and other microbes become resistant to the drugs used to treat them. This poses a grave risk, making common infections untreatable and potentially leading to increased mortality rates. It's a growing concern worldwide.

The Commitment The £210 million pledge encompasses a comprehensive approach, including research into new antibiotics, therapies, and diagnostics. It will also support global efforts to reduce the overuse of antibiotics in healthcare, agriculture, and the environment.

By investing in research and global collaboration, the UK government demonstrates its unwavering commitment to preserving the effectiveness of antibiotics and securing a healthier future for all.

Read more here:

https://www.gov.uk/government/news/210-million-to-tackle-deadly-antimicrobial-resistance

Get In Touch

We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.

Thank you we will get back to you shortly!

MO - FR 9:00 am - 5:00 pm

+ 420 774 557 550

info@baupharma.com

Czech Republic,
Nile House, Karolinská 654/2, Karlín, 186 00, Prague